球后注射曲安奈德治疗缺血性视神经病变的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of retrobulbar injection of Triamcinolone Acetonide in the treatment of ischemic optic neuropathy.Methods A total of 88 non arteritic anterior ischemic optic neuropathy （NAION）patients who were admitted to the First People′s Hospital of Nankang District from January to December 2019 were selected as the research objects.They were divided into control group and observation group by random number table method, with 44 cases in each group.The control group received Triamcinolone Acetonide injection next to the superficial temporal artery, and the observation group received Triamcinolone Acetonide injection after the ball.The clinical efficacy, visual recovery and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was higher than that in the control group, and the difference was statistically significant (P<0.05).The visual acuity level before treatment between the two groups was not statistically significant (P>0.05).The visual field MS levels between the two groups of patients after treatment were higher than those before treatment, and the visual field MS level of observation group was higher than that of the control group, the differences were statistically significant (P<0.05).The best corrected visual acuity, retinal nerve fiber layer thickness, and intraocular pressure of the two groups after treatment were lower than those before treatment, and the intraocular pressure of observation group was lower than that of the control group, the differences were statistically significant (P<0.05).There was no statistically significance in total incidence of adverse reactions between the two groups (P>0.05).Conclusion The retrobulbar injection of Triamcinolone Acetonide in the treatment of NAION is safe and reliable, and can improve the vision of patients.

Key words： Ischemic optic neuropathy Triamcinolone Acetonide Retrobulbar injection Clinical efficacy Vision recovery Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CAO Shipei
	XIE Xiaohua
	WU Fangling
	HE Yonghong
	ZENG Huan

Cite this article:

CAO Shipei,XIE Xiaohua,WU Fangling, et al. Effect of retrobulbar injection of Triamcinolone Acetonide in the treatment of ischemic optic neuropathy[J]. 中国当代医药, 2021, 28(36): 126-128.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I36/126

[1]	舒宝君，雷淑红，陈瑜，等.糖皮质激素联合高压氧治疗非动脉炎性前部缺血性视神经病变的疗效研究[J].广西医科大学学报，2019，36（2）：233-236.
[2]	关怀英，孔凡宏，张大卫，等.血栓通对非动脉炎性前部缺血性视神经病变患者视力、视野改善效果及作用机制分析[J].中国煤炭工业医学杂志，2018，21（1）：6-10.
[3]	陈凯，周洪伟.神经生长因子治疗非动脉炎性前部缺血性视神经病变的临床效果[J].中华眼视光学与视觉科学杂志，2020，22（10）：781-785.
[4]	刘宁姝，李世迎，孙成，等.巩膜后注射曲安奈德治疗糖尿病性黄斑水肿的疗效和安全性[J].中华实验眼科杂志，2017，35（7）：622-627.
[5]	郭晓娜，叶秀玲，张金嵩，等.后部眼球筋膜下注射曲安奈德治疗前部缺血性视神经病变[J].中华眼外伤职业眼病杂志，2019，41（5）：385-389.
[6]	杨旭，孙世龙，楚金亭，等.高压氧治疗非动脉炎性前部缺血性视神经病变的疗效观察[J].中华物理医学与康复杂志，2019，41（11）：829-832.
[7]	张雷，赵芳.复方樟柳碱两种不同使用方式治疗非增生性糖尿病视网膜病变的疗效[J].中华实验眼科杂志，2018，36（12）：970-972.
[8]	王瑾，吴惠琴，陈晓冬，等.羟苯磺酸钙联合复方樟柳碱治疗非增殖性糖尿病性视网膜病变临床研究[J].陕西医学杂志，2020，49（4）：489-493.
[9]	周伟民，曹文波，楚金亭，等.高压氧综合治疗对非动脉炎性前部缺血性视神经病变患者的临床疗效[J].中华航海医学与高气压医学杂志，2021，28（1）：87-91.
[10]	范晓梅，刘丽丹.醋酸曲安奈德玻璃体腔注射在治疗老年黄斑水肿患者中的应用[J].检验医学与临床，2018，15（2）：266-269.
[11]	赵恩贤，秦继跃.眼底激光联合曲安奈德治疗糖尿病性视网膜病变的疗效[J].国际眼科杂志，2018，18（11）：1963-1966.
[12]	周林，李芳芳.曲安奈德辅助23G 微创玻璃体切割治疗增生性糖尿病视网膜病变[J].中国现代手术学杂志，2018，22（4）：306-310.
[13]	台金岭，赵宪孟，李月礼，等.玻璃体腔注射康柏西普和曲安奈德治疗非动脉炎性前部缺血性视神经病变的比较研究[J].现代药物与临床，2020，35（12）：2400-2404.
[14]	吕旭东，龚兰兰，柴基桥.玻璃体腔内注射曲安奈德联合激光光凝治疗糖尿病性黄斑水肿32 例[J].医药导报，2019，38（1）：62-65.
[15]	张振坡，张金嵩，杨倩倩，等.曲安奈德后部眼球筋膜下注射与雷珠单抗玻璃体内注射治疗缺血性视神经病变的疗效对比[J].中华眼外伤职业眼病杂志，2019，41（61）：450-453.